Rational centre selection for rcts with a parallel economic evaluation - The next step towards increased generalisability?

Health Economics (United Kingdom)

Volumn 24, Issue 4, 2015, Pages 498-504

  Gheorghe, Adrian ^a,b   Roberts, Tracy ^a   Pinkney, Thomas D ^c   Morton, Dion G ^c   Calvert, Melanie ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

centre; economic evaluation; generalisability; location; randomised controlled trials

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE POLICY; HEALTH CENTER; HEALTH ECONOMICS; HUMAN; MULTICENTER STUDY (TOPIC); PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STUDY DESIGN; COST BENEFIT ANALYSIS; PROCEDURES; STANDARDS;

COST-BENEFIT ANALYSIS; HUMANS; MULTICENTER STUDIES AS TOPIC; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84924655702     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.3039     Document Type: Article

References (32)

1. Antonanzas F, Rodriguez-Ibeas R, Juarez C, Hutter F, Lorente R, Pinillos M,. 2009. Transferability indices for health economic evaluations: methods and applications. Health Economics 18: 629-643.
2. Bojke C, Castelli A, Street A, Ward P, Laudicella M,. 2013. Regional variation in the productivity of the english national health service. Health Economics 22: 194-211.
3. Boulenger S, Nixon J, Drummond M, Ulmann P, Rice S, De Pouvourville G,. 2005. Can economic evaluations be made more transferable? European Journal of Health Economics 6: 334-346.
4. Cookson R, Laudicella M,. 2011. Do the poor cost much more? The relationship between small area income deprivation and length of stay for elective hip replacement in the English NHS from 2001 to 2008. Social Science & Medicine 72: 173-184.
5. Coyle D, Drummond MF,. 2001. Analyzing differences in the costs of treatment across centers within economic evaluations. International Journal of Technology Assessment in Health Care 17: 155-163.
6. Department of Health. 2013. PbR and the Market Forces Factor (MFF) in 2013-14. Available: https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/141395/PbR-and-the-MFF-in-2013-14.pdf.pdf Accessed 11/07/2013.
7. Drummond M, Manca A, Sculpher M,. 2005. Increasing the generalizability of economic evaluations: Recommendations for the design, analysis, and reporting of studies. International Journal of Technology Assessment in Health Care 21: 165-171.
8. Drummond M, Barbieri M, Cook J, Glick HA, Lis, J, Malik F, Reed SD, Rutten F, Sculpher M, Severens J,. 2009. Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. Value in Health 12: 409-418.
9. Fenwick E, Claxton K, Sculpher M,. 2001. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Economics 10: 779-787.
10. Gheorghe A, Roberts TE, Ives JC, Fletcher BR, Calvert M,. 2013. Centre Selection for Clinical Trials and the Generalisability of Results: A Mixed Methods Study. PLoS ONE 8: e56560.
11. Glick HA, Orzol SM, Tooley JF, Polsky D, Mauskopf JO,. 2003. Design and analysis of unit cost estimation studies: How many hospital diagnoses? How many countries? Health Economics 12: 517-527.
12. Goeree R, Gafni A, Hannah M, Myhr T, Blackhouse G,. 1999. Hospital Selection for Unit Cost Estimates in Multicentre Economic Evaluations: Does the Choice of Hospitals Make a Difference? PharmacoEconomics 15: 561-572.
13. Goeree R, Burke N, O'Reilly D, Manca A, Blackhouse G, Tarride JE,. 2007. Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another. Current Medical Research & Opinion 23: 671-682.
14. Goeree R, He J, O'Reilly D, Tarride JE, Xie F, Lim M, Burke N,. 2011. Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application. ClinicoEconomics and Outcomes Research 3: 89-104.
15. Grieve R, Cairns J, Thompson, SG,. 2010. Improving costing methods in multicentre economic evaluation: the use of multiple imputation for unit costs. Health Economics 19: 939-954.
16. Laudicella M, Olsen KR, Street A,. 2010. Examining cost variation across hospital departments - a two-stage multi-level approach using patient-level data. Social Science & Medicine 71: 1872-1881.
17. Manca A, Willan AR,. 2006. 'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data. PharmacoEconomics 24: 1101-1119.
18. Manca A, Rice N, Sculpher MJ, Briggs AH,. 2005. Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models. Health Economics 14: 471-485.
19. Manca A, Lambert PC, Sculpher M, Rice, N,. 2007. Cost-effectiveness analysis using data from multinational trials: the use of bivariate hierarchical modeling. Medical Decision Making 27: 471-490.
20. Manca A, Sculpher MJ, Goeree R,. 2010. The analysis of multinational cost-effectiveness data for reimbursement decisions: a critical appraisal of recent methodological developments. PharmacoEconomics 28: 1079-1096.
21. National Institute for Health and Clinical Excellence 2013. Guide to the Methods of Technology Appraisal 2013. NICE: London.
22. NHS The Information Centre for Health and Social Care. 2013. Quality and Outcomes Framework-Online GP practice results database. [Online]. Available: http://www.qof.ic.nhs.uk/ Accessed 28/08/2013.
23. Petrinco M, Pagano E, Desideri A, Bigi R, Ghidina M, Ferrando A, Cortigiani L, Merletti F, Gregori D,. 2009. Information on Center Characteristics as Costs' Determinants in Multicenter Clinical Trials: Is Modeling Center Effect Worth the Effort? Value in Health 12: 325-330.
24. Pinkney TD, Bartlett DC, Hawkins W, Mak T, Youssef H, Futaba K, Harrison G, Gheorghe A, Bradbury JM, Calvert MJ, Dowswell G, Magill L, Redman V, Wilson S, Leaper D, Morton DG, West Midlands Research, C. 2011. Reduction of surgical site infection using a novel intervention (ROSSINI): study protocol for a randomised controlled trial. Trials [Electronic Resource] 12: 217.
25. Pinkney TD, Calvert M, Bartlett DC, Gheorghe A, Redman V, Dowswell G, Hawkins W, Mak T, Youssef H, Richardson C, Hornby S, Magill L, Haslop R, Wilson S, Morton D,. 2013. Impact of wound edge protection devices on surgical site infection after laparotomy: multicentre randomised controlled trial (ROSSINI Trial). BMJ 347: f4305.
26. Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A,. 2004. Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technology Assessment 8: 1-192.
27. Shadish WR, Cook TD, Campbell DT,. 2002. Experimental and quasi-experimental designs for generalized causal inference. Houghton Mifflin Company: Boston.
28. Sharpe N,. 2002. Clinical Trials and the Real World: Selection Bias and Generalisability of Trial Results. Cardiovascular Drugs and Therapy 16: 75-77.
29. Stinett AA, Mullahy J,. 1998. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Medical Decision Making 18 (2 Suppl): S68-S80.
30. Turner S, Chase DL, Milne R, Cook A, Hicks NJ, Rosten C, Payne L, Coles S, Bell E,. 2009. The health technology assessment adaptation toolkit: Description and use. International Journal of Technology Assessment in Health Care 25: 37-41.
31. Welte R, Feenstra T, Jager H, Leidl R,. 2004. A decision chart for assessing and improving the transferability of economic evaluation results between countries. PharmacoEconomics 22: 857-876.
32. Willke RJ, Glick HA, Polsky D, Schulman K,. 1998. Estimating country-specific cost-effectiveness from multinational clinical trials. Health Economics 7: 481-493.